INS and diabetes mellitus: GIP stimulates also glucose-dependent insulin release in people without diabetes and may have a role in appetite regulation: despite mixed findings, preclinical research suggests that the addition of GIP RA may enhance appetite suppression and WL associated with a fixed-dose of GLP-1 RA (Fig. 1) [16, 19].